{
    "paper_id": "22c6394906d38d682e6c5c160a8c62e376db30e7",
    "metadata": {
        "title": "A",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "(FH), 385\u00c0386 FV. See Factor V (FV) FVL. See Factor V Leiden (FVL) FXI. See Factor XI (FXI) FXIII. See Laki Lorand Factor (FXIII) G G143E, 464 G1691A. See Factor V Leiden (FVL), R506Q mutation G6PD. See Glucose-6-phosphate dehydrogenase (G6PD) Gain-of-function mutations, 325\u00c0326 Ganciclovir, 94\u00c095 Ganetespib, 297\u00c0298 Gangliotetraosylceramide-bissulfate (SB1a), 521\u00c0522 Gangliotriosylceramide sulfate (SM2a),",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Somatic genomic testing, 407 Sonic hedgehog (SHH)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Solid organ transplant (SOT) Sotalol",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sot",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "466--467",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "SOX10. See SRY-related HMG-box 10 (SOX10) Special care baby unit (SCBU)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Specimen collection, 131\u00c0132 Specimen Transport Medium (STM)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Spitz nevus",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Spitzoid malignant melanomas (SMMs)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "SRY-related HMG-box 10 (SOX10)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "326--328",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "See Sessile serrated adenomas (SSAs) SSI. See Surgical site infection (SSI) SSRIs. See Selective serotonin reuptake inhibitors (SSRIs)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ssas",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Signal transducer and activator of transcription 3 (STAT3)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Stat3",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "464\u00c0465 clinical utility, 465\u00c0466 genes association with statin myopathy",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Statins",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "458",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Sexually transmitted infections (STIs) STM. See Specimen Transport Medium (STM)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Stis",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "See Short tandem repeats (STRs) Strand displacement amplification (SDA)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Strs",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Stratification of medicines",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Succinate dehydrogenase (SDH), 385\u00c0386 Sudden cardiac death (SCD)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Surface\u00c0enhanced laser desorption and ionization time-of-flight (SELDI\u00c0TOF)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Surgical site infection (SSI)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "163--164",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Suspicious for Malignancy (SUSP) Suspicious for Malignancy (SUSP)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Susp",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "394--395",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Sustained virologic response (SVR)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Svr",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "SWI/SNF-related, matrix-associated, actindependent regulator of chromatin, subfamily a",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "521\u00c0522 Gardnerella vaginalis, 157 GAS. See Group A Streptococcus (GAS) Gastrointestinal infections, 143. See also Bloodstream infections; Respiratory infections molecular target(s) and technologies, 143\u00c0144 clinical utility, 144 FDA-cleared multiplex gastrointestinal tests, 144t limitations of testing, 144\u00c0145 Gastrointestinal tract (GI tract), 89\u00c090, 143 GATA4, 461 GB virus C (GBV-C), 70 and molecular detection, 70\u00c071 GBM. See Glioblastoma (GBM) GBS. See Group B Streptococcus (GBS) GBV-C. See GB virus C (GBV-C) GC. See Genomic classifier (GC) GCN. See Gene copy number (GCN) GDH. See Glutamate dehydrogenase (GDH) Gefitinib, 296\u00c0297 Gel electrophoresis (DIGE), 353 Gelatin, 18\u00c019 Gemfibrozil, 465 Gen-Probe Accuprobe GBS test, 147",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "See Cerebrospinal fluid (CSF) CT. See Computed tomography (CT) CTCs. See Circulating tumor cells (CTCs) ctDNA. See circulating tumor DNA (ctDNA) CTNNB1. See Catenin beta 1 (CTNNB1) CTP. See Chuvash-type polycythemia (CTP) CTRB. See Chymotrypsinogen B (CTRB) Cumulative sun-damaged skin (CSD), 323 CVS. See Chorionic villus sampling (CVS)",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "GNA11. See Guanine nucleotide binding protein alpha 11 (GNA11) GNAQ. See Guanine nucleotide binding protein q polypeptide (GNAQ) GNAS mutation, 393 Gold-standard germline testing, 307\u00c0308 Gonococcal genital infection, 153\u00c0154 Gonorrhea diseaseSyphilis, diseaseTrichomoniasis disease diagnosis, 154 epidemiology, 153\u00c0154 nucleic acid tests for gonococcal infection, 154 GPS. See Genomic Prostate Score (GPS) Graft rejection, 451\u00c0452 Graft versus host disease (GVHD), 95, 449, GVL activity. See Graft-versus-leukemia activity (GVL activity) GWAS. See Genome-wide association studies (GWAS) Gynecologic cancer, 361. See also Pancreatic cancer; Pediatric cancers; Thyroid See Hepatitis A virus (HAV) HB. See Hemophilia B (HB) HBsAg. See HBV surface antigen (HBsAg) HBV. See Hepatitis B virus (HBV) HBV surface antigen (HBsAg), 64\u00c065 HC. See Hemochromatosis (HC)Hemophilia C (HC) HCC. See Hepatocellular carcinoma (HCC) HCM. See Hypertrophic cardiomyopathy (HCM) HCoV. See Human coronavirus (HCoV) HCT. See Hematopoietic cell transplant 494\u00c0495 serological and molecular profiles of HCV infection, 68f HCV. See Hepatitis C virus (HCV) HDV. See Hepatitis D virus (HDV) Healthcare-acquired infections (HAIs), JARID1C UTX, MLL2, 383 HIV. See Human immunodeficiency virus (HIV) HJV gene. See Hemojuvelin gene (HJV gene) hK2. See human kallikrein 2 (hK2) HLA class II alleles, 480\u00c0481 HLRCC. See Hereditary leiomyomatosis renal cell carcinoma (HLRCC) HMB45 cytoplasmic marker, 326 HME. See Human monocytotropic ehrlichiosis (HME) HMPS. See Hereditary mixed polyposis syndrome (HMPS) HMPV. See Human metapneumovirus (HMPV) HNPCC. See Hereditary nonpolyposis colorectal cancer (HNPCC) HO. See Hospital onset (HO) See Lowest limit of detection (LLD) LLOD. See Lower limit of detection (LLOD) LLOQ. See Lower limit of quantitation (LLOQ) LMV. See Lamivudine (LMV) lncRNA. See Long noncoding RNA (lncRNA) LOD. See Limit of detection (LOD) LOH. See Loss of heterozygosity (LOH) NA. See Neuraminidase (NA) NATUS. PRSS2 preproprotein. See Serine proteinase 2 preproprotein (PRSS2 preproprotein) PS. See Pancreatic sufficient (PS) PSA. See prostate-specific antigen (PSA) Pseudokinase domain (JH2 domain), 435 Pseudomembranous colitis (PMC), 169 PSTI. See Pancreatic secretory trypsin inhibitor (PSTI) PSTT. See Placenta site trophoblastic tumor (PSTT) PT. See Prothrombin (PT) PTEN. See Phosphatase and tensin homologue (PTEN) PTLD. See Posttransplant lymphoproliferative disorder (PTLD) Public health screening, 538 Pulsed field gel electrophoresis (PFGE), 167, 172 Pure red cell aplasia (PRCA), 104\u00c0105 Purulent discharge. See \"Pissing glass\" PV. See Polycythemia vera (PV) Pyridoxamine, 521\u00c0522, 521f Pyrosequencing, 140, 343\u00c0344 Q80K mutational variant, 495 qPCR. See quantitative PCR (qPCR) Qualitative assays, 415 quantitative PCR (qPCR), 40, 106\u00c0107, 116, 439 assay design, 107, 107f assay validation, 107\u00c0108 result interpretation and relevance, 109\u00c0110 Quantitative real-time PCR methods, 95 See Secreted apoptosis\u00c0related protein\u00c02 gene (SARP2 gene) SARS-CoV. See Severe acute respiratory syndrome associated CoV (SARS-CoV) SB1a. See Gangliotetraosylceramidebissulfate (SB1a) SBS. See Sequencing by Synthesis (SBS) SCAs. See Segmental chromosome abnormalities (SCAs)Sex chromosome aneuploidies (SCAs) SCBU. See Special care baby unit (SCBU) SCC. See Staphylococcal chromosomal cassette (SCC) SCD. See Sudden cardiac death (SCD) SChLAP1, 273\u00c0274 SCLC. See Small cell lung cancer (SCLC) SCNAs. See Somatic copy number alterations (SCNAs) Screening of blood products, 52\u00c053 SDA. See Strand displacement amplification (SDA) SDH. See Succinate dehydrogenase (SDH) SDH-associated kidney cancer, 385\u00c0386 Seasonality, 133 Secondary bacterial pneumonia, 126 multiplex approach of STI diagnosis using molecular tools, 158\u00c0159 POC diagnostics for STIs, 159 vaginal microbiome and STIs, 157 genital chlamydia infection, 154\u00c0155 gonorrhea disease, 153\u00c0154 mycoplasma genitalium infection, 156 syphilis disease, 151\u00c0153 trichomoniasis disease, 156\u00c0157 SHEA. See Society for Healthcare Epidemiology of America (SHEA) SHH. See Sonic hedgehog (SHH) Single nucleotide variants (SNVs), 40 Single-probe technique, 258 Single\u00c0base extension assays, 394 Skin cancer, 522 SLC11A2 gene mutations, 247\u00c0248 SLCO1B1 gene, 465 SM2a. See Gangliotriosylceramide sulfate (SM2a) SM3. See Sulfoactoceramide (SM3) SM4s. See Sulfogalactoceramide (SM4s) Small cell lung cancer (SCLC), 287 SMARCA4. See SWI/SNF-related, matrixassociated, actin-dependent regulator of chromatin, subfamily a, member 4 (SMARCA4) SMMs. See Spitzoid malignant melanomas (SMMs) SMRT sequencing. See Single Molecule Real Time sequencing (SMRT sequencing) SN. See Spitz nevi (SN) SN-38 glucoronic acid (SN-38G), 505 SNaPshot, 41 SNF complex, 383 SNP. See Single nucleotide polymorphism (SNP) SNVs. See Single nucleotide variants (SNVs) Syndromic disorders, 216 Syphilis, 152. See also Gonorrhea disease; Trichomoniasis disease disease diagnosis, 152, 153f epidemiology, 151\u00c0152 place of syphilis molecular testing, 152\u00c0153 T T-DM1. See Ado-trastuzumab emtansine (T-DM1) T21. See Trisomy 21 (T21) T311. See Tyrosinase T315I. See Threonine 315 (T315I) TA. See Thymine-adenine (TA) Tag-IT Luminex platform, 508 Taq polymerase, 15\u00c016, 19 TaqMan real-time PCR, 450 Target amplification, 139 Target cell, 76 Target not detected (TND), 494 Target sequence, 16\u00c017 Targeted therapy, 241, 280\u00c0281, 287\u00c0288 ALK-targeted therapy, 297\u00c0298 EGFR-targeted therapy, 296\u00c0297 KRAS/MEK-targeted therapy, 297\u00c0298 TAT. See Turnaround time (TAT) Taxanes, 332 TCGA. See The Cancer Genome Atlas (TCGA) Tegafur, 503 Telaprevir (TVR), 489 Telomerase reverse transcriptase (TERT), 326, 393 Temozolamide (TMZ), 332, 345 Temperature, 17 TERT. See Telomerase reverse transcriptase (TERT) TF. See Tissue factor (TF) TF gene mutations. See Transferrin gene mutations (TF gene mutations) TFPI. See Tissue factor pathway inhibitor (TFPI) TFR2 gene. See Transferrin receptor 2 gene (TFR2 gene) TGF\u03b1. See Transforming growth factor alpha (TGF\u03b1) TGF\u03b2. See Transforming growth factor-\u03b2 (TGF\u03b2) TGNs. See Thioguanine nucleotides (TGNs) THBS1. See Thrombospondin\u00c01 (THBS1) The Cancer Genome Atlas (TCGA), 384, 391 Therapeutic INR range (TTR), 461 Thermal cycler, 35\u00c036, 36f Thermolabile variant C665T, 223 Thermus aquaticus, 15\u00c016 Thioguanine, 510t THBS1), 349\u00c0350 Thymine-adenine (TA), 505 Thyroid cancer, 391. See also Gynecologic cancer; Pancreatic cancer; Pediatric cancers clinical utility, 394\u00c0396 limitations of testing, 396 molecular targets, 391\u00c0393 mutations in thyroid tumors, 392t molecular technologies, 393\u00c0394 Thyroid nodules, 394\u00c0395 Thyroid specimens testing, 393 Thyroid transcription factor-1 (TTF-1), 287 Ticlopidine, 480f Time-of-flight (TOF), 518 Tirofiban, 480f Tissue biopsy, 12\u00c013 Tissue factor (TF), 477 Tissue factor pathway inhibitor (TFPI), 477 TK. See Tyrosine kinase (TK) TKIs. See Tyrosine kinase inhibitors (TKIs) TMA. See Transcription-mediated amplification (TMA) TMPRSS2:ERG gene rearrangement, 272\u00c0273, 277\u00c0280 TMZ. See Temozolamide (TMZ) TND. See Target not detected (TND) TOF. See Time-of-flight (TOF) Toxin production, 169 TP53 gene. See Tumor\u00c0suppressor gene (TP53 gene) TP53. See Tumor protein p53 (TP53) TPMT. See Thiopurine methyltransferase (TPMT) Trametinib, 323, 332 Transcription-mediated amplification (TMA), 52\u00c053, 78, 81, 154, 273\u00c0274 Transferrin gene mutations (TF gene mutations), 249\u00c0250 Transferrin receptor 2 gene (TFR2 gene), 245 Transferrin saturation (TS), 246\u00c0250, 249f Transforming growth factor alpha (TGF\u03b1), 289, 339 Transforming growth factor-\u03b2 (TGF\u03b2), 306, 309 TGF\u00c0\u03b21, 354 Transmission, 104 Trastuzumab, 258 Treponema pallidum, 151\u00c0152 Trichomoniasis disease. See also Gonorrhea disease; Syphilis, disease diagnosis on conventional techniques, 156 molecular testing, 157 epidemiology, 156 Trilateral RB, 401 Triple-negative breast cancer, 13 Trisomy 21 (T21), 203 \"True variant\" threshold, 31 TRUGENE test, 67 Trypsin, 520, 526 TS. See Transferrin saturation (TS) TTF-1. See Thyroid transcription factor-1 (TTF-1) TTR. See Therapeutic INR range (TTR) Tuberculosis diagnosis, 139 Tumor protein p53 (TP53), 325 Tumorigenesis, 287 Tumor\u00c0suppressor gene (TP53 gene), 429 Turnaround time (TAT), 194 Turner syndrome, 225 TVR. See Telaprevir (TVR) Type 2 vWD subtypes, 227 Type 2M vWD, 228 Type 3 vWD, 228 Type I deficiency, 224 Type I vWD, 227 Type II deficiency subtypes, 224 Tyramide, 341\u00c0342 Tyrosinase, 328 Tyrosine kinase (TK), 287\u00c0288, 289f Tyrosine kinase domain (JH1 domain), 435 Tyrosine kinase inhibitors (TKIs), 39\u00c040, 287, 290, 295\u00c0296, 344\u00c0345, 413, 424, 457 TKI resistance, 417 mutations in ALK, 291\u00c0292, 292f mutations in EGFR, 290 UPD. See Uniparental disomy (UPD) Upper respiratory tract infection (URTI), 123 Upper respiratory tract infections. See also Lower respiratory tract infections cold, 129, 129t ILI, 129\u00c0130 UQCRH. See Ubiquinol\u00c0cytochromec reductase hinge protein (UQCRH) URTI. See Upper respiratory tract infection (URTI) US Food and Drug Administration (FDA), 77\u00c078, 193, 294, 439, 457\u00c0458, 490 Uterine cervical cancer, 361\u00c0363 uTIMPs. See urinary levels of tissue inhibitor of metalloproteases (uTIMPs) UTRs. See Untranslated regions (UTRs) UTX, 383 UV light. See Ultraviolet light (UV light) Uveal melanomas, 323, 328 V V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, 323 Vaccine, 77\u00c078 Vaginal microbiome and STIs, 157 Valganciclovir, 94\u00c095 Vancomycin, 146, 165\u00c0166 Vandetanib, 395\u00c0396 Variant calling, 30\u00c031 isoform, 421 Variant Call Format (VCF), 31 Variant of unknown significance (VUS), 533 Varicella zoster virus (VZV), 89, 90t, 92 Vascular endothelial growth factor (VEGF), 382 VCF. See Variant Call Format (VCF) VEGF. See Vascular endothelial growth factor (VEGF) Vemurafenib, 25\u00c026, 311, 323, 332, 395\u00c0396 Venous thromboembolism (VTE), 476\u00c0477 polymorphism association with, 478 Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-GP Test), 146 Verinata Health. See Illumina vge. See Virus genome equivalents (vge) VHL disease. See von Hippel-Lindau disease (VHL disease) Viral DNA, 105\u00c0106 Viral polymerases, 489 Viral resistance variants, 495\u00c0497 Viral respiratory infection (VRI), 131 Virchow's triad, 478 Virion, 49 Virtual phenotype resistance assay (VirtualPhenotype assay), 57\u00c058 224\u00c0225 Vitamin K epoxide reductase complex subunit 1 (VKORC1), 224, 458\u00c0460, 460f von Hippel-Lindau disease (VHL disease), 228, 381\u00c0382 von Willebrand disease (vWD), 221, 227\u00c0228 von Willebrand factor gene (vWF gene), 227\u00c0228 VRI. See Viral respiratory infection (VRI) VTE. See Venous thromboembolism (VTE) VUS. See Variant of unknown significance (VUS) vWD. See von Willebrand disease (vWD) vWF gene. See von Willebrand factor gene (vWF gene) vWF Thr789Ala polymorphism, 476 VZV. See Varicella zoster virus (VZV) W515A mutation, 436\u00c0437 W515K mutation, 436\u00c0437 W515L mutation, 436\u00c0437 W515R mutation, 436\u00c0437 WAGR syndrome. See Wilms 458\u00c0460 Warfarin stable dose (WSD), 458 WAS. See Wiskott-Aldrich syndrome (WAS) WES. See Whole exome sequencing (WES) WGS. See Whole genome sequencing (WGS) WHO. See World Health Organization (WHO) Whole exome sequencing (WES), 218, 531 Whole genome sequencing (WGS), 218, 531. range genomic interactions, 536f for oncology applications, 538 molecular technology, 531 CGS variants, 533\u00c0535 cost of sequencing, 532f incidental findings and ethical, legal, and social implications, 535 interpreting variants in CGS, 533 limitations of CGS, 532\u00c0533 validation of discoveries from genome sequencing, 534f optimism, 539 Wilms tumor (WT), 401, 403 clinical utility, 405 congenital syndromes associated with increased risk of, 404t genetic testing, 404 karyotype of tumor cell from young male WT patient, 406f limitations of testing, 405\u00c0406 molecular target, 403\u00c0404 molecular technologies, 404\u00c0405 WSD. See Warfarin stable dose (WSD) WT. See Wilms tumor (WT) Wukipolyomavirus genus, 115 xTAG liquid bead array, 239 Zanamivir, 133\u00c0134 Zone of polarizing activity regulatory sequence (ZRS), 537",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}